Navigation Links
Jazz Pharmaceuticals Announces Presentation at the Lazard Capital Markets Healthcare Conference on November 17
Date:11/11/2010

PALO ALTO, Calif., Nov. 11, 2010 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that Bruce Cozadd, the company's chairman and chief executive officer, will present at the Lazard Capital Markets Healthcare Conference in New York on Wednesday, November 17, 2010 at 9:00 a.m. Eastern Time.

A live webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

An archived version of the webcast will be available for at least one week on the Investors section of the company's website at www.jazzpharmaceuticals.com.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals (Nasdaq: JAZZ) is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information see www.jazzpharmaceuticals.com.


'/>"/>
SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... STAMFORD, Conn. , Aug. 31, 2015 /PRNewswire/ ... Ltd., and Purdue Pharma L.P. announced today that they ... development and commercialization of Eisai,s clinical candidate lemborexant (development ... III clinical development for the treatment of insomnia. ... and Purdue Pharma will share the costs of lemborexant ...
(Date:8/31/2015)... 2015 Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical ... therapeutics for the treatment of diseases of the central ... BNC101 IND submission has passed review by the US ... a Phase 1 clinical trial in patients with metastatic ... prior to 31 December 2015. Bionomics, CEO ...
(Date:8/31/2015)... , Aug. 31, 2015 Research ... addition of the "Prescription Pain Drugs - ... Marijuana - Global Markets, Competitors and Opportunities: 2015 ... their offering. Pain is defined ... with actual or potential tissue damage. At some ...
Breaking Medicine Technology:Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3
... DIEGO, Jan. 7, 2011 ADVENTRX Pharmaceuticals, Inc. (NYSE ... has entered into definitive agreements to sell 8,184,556 units ... certain healthcare-focused investors, and other institutional investors for a ... to ADVENTRX of approximately $22.5 million.  Each unit consists ...
... Jan. 7, 2011 WaferGen Biosystems, Inc. (OTC Bulletin ... state-of-the-art genomic analysis systems, today announced that it will ... Annual OneMedForum Business Development and Investment Conference for emerging ... JP Morgan Healthcare Conference in San Francisco, January 11-13, ...
Cached Medicine Technology:ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million 2ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million 3WaferGen to Present at OneMedForum San Francisco 2011 2
(Date:9/1/2015)... ... ... Dr. Trace Curry successfully placed one of the first ORBERA™ Intra-gastric Balloons in ... has approved two intra-gastric balloons, the ORBERA ™ Managed Weight Loss System and ... loss procedures available to Americans. , Dr. Curry, medical director at JourneyLite, ...
(Date:9/1/2015)... ... September 01, 2015 , ... Award-winning adult film director and ... experiences of female beauty, women’s emotions, fertility, female violence and sexual assault. She ... their relationships with other men, documenting how the power balance between men and ...
(Date:9/1/2015)... ... ... A new episode of “Voices In America”, hosted by famous actor and ... arthritis. There are over 100 different types of arthritis. One of the most popular ... effort to shed light on this important topic. , Anyone who is nearing their ...
(Date:9/1/2015)... ... September 01, 2015 , ... The ... Systems, has become a leader in podiatric, surgical and wound care ... Superwounds Conferences place top national speakers at the podium and across the table ...
(Date:8/31/2015)... , ... September 01, 2015 , ... ... eliminate chronic back pain – once required a long, arduous recovery. However, today’s ... stay, less pain, less blood loss and minimal muscle damage. These advantages of ...
Breaking Medicine News(10 mins):Health News:Dr. Trace Curry Performs First ORBERA™ Intra-gastric Balloon in Ohio at JourneyLite, a New Incisionless Option For The Treatment of Obesity 2Health News:Female Porn Director Explains Male Insecurities about Women in a New Book 2Health News:PRESENT e-Learning Systems Announces their 2016 Podiatry and Wound Care Medical Education Conference Schedule 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 3Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 4
... HealthDay Reporter , TUESDAY, Oct. 18 (HealthDay News) -- ... lose weight, other family members may be more likely to ... tracked the spouses, children and other family members living in ... bypass surgery. The patients and their family members attended three ...
... Interactive Autism Network (IAN Project) launches a national survey ... autism spectrum disorders (ASD). Bullying, a pervasive problem among ... because of the lasting, and sometimes tragic, effects on ... are believed to be especially vulnerable targets due to ...
... -- In October 2011 the National Institute of Justice ... capstone project proposal in the Master of Forensic Science ... designer drugs known as "Bath Salts" (beta-keto-amphetamines or BKAs). ... enforcement and forensic scientists for decades, but more recently ...
... If genes provide the blueprint for life and proteins ... cells, then carbohydrates that are linked to proteins are among ... world and each other. But until now, scientists have been ... GAG proteoglycanor even to agree whether these remarkably complex molecules ...
... radically changed the way surgeons practice medicine, and nowhere ... gynecologic endoscopy. AAGL, the oldest professional organization devoted ... will showcase a number of innovative surgical approaches and ... practice labs offered at its annual Global Congress, November ...
... (Washington) Fears about re-uses of personal data as well ... of a policy paper released today by the American College ... update of a paper produced by ACP two years ago, ... privacy rule that says researchers should maximize appropriate uses of ...
Cached Medicine News:Health News:Weight Loss Surgery Can Help Whole Families: Study 2Health News:Weight Loss Surgery Can Help Whole Families: Study 3Health News:National survey will measure how bullying impacts children with autism 2Health News:Detecting 'bath salts' designer drug 2Health News:UGA scientists team up to define first-ever sequence of biologically important carbohydrate 2Health News:UGA scientists team up to define first-ever sequence of biologically important carbohydrate 3Health News:Innovations in minimally invasive surgery and education are highlights of 40th AAGL Global Congress 2Health News:Innovations in minimally invasive surgery and education are highlights of 40th AAGL Global Congress 3Health News:Innovations in minimally invasive surgery and education are highlights of 40th AAGL Global Congress 4Health News:Internists address dual concerns of privacy and protection of health data 2Health News:Internists address dual concerns of privacy and protection of health data 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: